USOO9663587B2 (12) United States Patent (10) Patent No.: US 9,663,587 B2 Hsieh et al. (45) Date of Patent: May 30, 2017 (54) IL-17 BINDING PROTEINS 4,753,894 A 6, 1988 Frankel et al. 4,816,397 A 3, 1989 BOSS et al. 4,816,567 A 3/1989 Cabilly et al. (71) Applicant: AbbVie Inc., North Chicago, IL (US) 4,880,078 A 11/1989 Inoune et al. 4,943,533 A 7, 1990 Mendelsohn et al. (72) Inventors: Chung-Ming Hsieh, Newton, MA 4.946,778 A 8, 1990 Ladner et al. (US); Margaret Hugunin, North 4,980,286 A 12/1990 Morgan et al. Grafton, MA (US); Anwar Murtaza, 5,006,309 A 4, 1991 Khali1 et al. 5,063,081 A 11/1991 Cozzette et al. Westborough, MA (US); Bradford L. 5,089,424 A 2f1992 Khali1 et al. McRae, Northborough, MA (US); 5,128,326 A 7, 1992 Balazs et al. Yuliya Kutskova, Northborough, MA 5,135,875 A 8, 1992 Meucci et al. (US); John E. Memmott, Framingham, 5,223,409 A 6/1993 Ladner et al. MA (US); Jennifer M. Perez, 5,225,539 A 7, 1993 Winter 5,241,070 A 8, 1993 Law et al. Worcester, MA (US); Suju Zhong, 5,242,828 A 9/1993 Bergstrom et al. Shrewsbury, MA (US); Edit Tarcsa, 5,258.498 A 11/1993 Huston et al. Westborough, MA (US); Anca 5,290,540 A 3, 1994 Prince et al. Clabbers, Rutland, MA (US); Craig 5,294.404 A 3/1994 Grandone et al. Wallace, Sterling, MA (US); Shaughn 5,352,803 A 10/1994 Mattingly 5,359,093 A 10/1994 Adamczyk et al. H. Bryant, Worcester, MA (US); Mary 5,403.484 A 4/1995 Ladner et al. R. Leddy, North Attleboro, MA (US) 5,427,908 A 6/1995 Dower et al. 5,468,646 A 11/1995 Mattingly et al. (73) Assignee: ABBVIE INC., North Chicago, IL (US) 5,496.925 A 3/1996 Mattingly 5,500,362 A 3, 1996 Robinson et al. (*) Notice: Subject to any disclaimer, the term of this 5,516,637 A 5/1996 Huang et al. 5,530,101 A 6/1996 Queen et al. patent is extended or adjusted under 35 5,543,524 A 8/1996 Mattingly et al. U.S.C. 154(b) by 98 days. 5,558,864 A 9/1996 Bendig et al. 5,565,332 A 10/1996 Hoogenboom et al. (21) Appl. No.: 14/262,653 5,565,352 A 10, 1996 Hochstrasser et al. 5,571,698 A 11/1996 Ladner et al. (22) Filed: Apr. 25, 2014 5,573,904 A 11/1996 Mattingly (Continued) (65) Prior Publication Data FOREIGN PATENT DOCUMENTS US 2014/034.8856 A1 Nov. 27, 2014 CA 2 679 266 A1 9, 2008 Related U.S. Application Data EP O471293 A2 2, 1992 (62) Division of application No. 12/718,841, filed on Mar. (Continued) 5, 2010, now Pat. No. 8,835,610. (60) Provisional application No. 61/209.272, filed on Mar. OTHER PUBLICATIONS 5, 2009. Jonsson, et al., “Real-Time Biospecific Interaction Analysis Using Surface Plasmon Resonance and a Sensor Chip Technology.” (51) Int. Cl. Biotechniques, 11(5): 620-627 (1991). C07K I6/46 (2006.01) Jonsson et al., “Introducing a biosensor based technology for C07K 6/24 (2006.01) real-time biospecific interaction analysis.” Ann. Biol. Clin. 51: A 6LX 39/395 (2006.01) 19-26 (1993). A61 K 39/00 (2006.01) Jovanovic et al., “IL-17 stimulates the production and expression of proinflammatory cytokines, IL-13 and TNA-a, by human (52) U.S. Cl. macrophages,” J. Immunol. 160: 3513-3521 (1998). CPC ........ C07K 16/468 (2013.01); A61K 39/3955 Jungbluth et al., “A monoclonal antibody recognizing human can (2013.01); C07K 16/241 (2013.01); C07K cers with amplification/overexpression of the human epidermal I6/244 (2013.01); A61 K 2039/505 (2013.01); growth factor receptor.” Proc. Natl. Acad. Sci. USA, 100(2): 639 A6 IK 2039/507 (2013.01); A61 K 2300/00 644 (2003). (2013.01); C07K 231.6/96 (2013.01); C07K (Continued) 2317/21 (2013.01); C07K 23.17/31 (2013.01); C07K 2317/50 (2013.01); C07K 231 7/565 Primary Examiner — Brad Duffy (2013.01); C07K 2317/64 (2013.01); C07K Assistant Examiner — Nelson B Moseley, II 2317/76 (2013.01); C07K 2317/92 (2013.01) (74) Attorney, Agent, or Firm — Sterne, Kessler, (58) Field of Classification Search Goldstein and Fox P.L.L.C. None See application file for complete search history. (57) ABSTRACT Proteins that bind IL-17 and/or IL-17F are described along (56) References Cited with their use in composition and methods for treating, preventing, and diagnosing IL-17 related diseases and for U.S. PATENT DOCUMENTS detecting IL-17 in cells, tissues, samples, and compositions. 4,526,938 A 7, 1985 Churchill et al. 4,554,101 A 11/1985 Hopp 45 Claims, No Drawings US 9,663,587 B2 Page 2 (56) References Cited 2005.0054078 A1 3, 2005 Miller et al. 2005, 0147610 A1 7/2005 Ghayur et al. U.S. PATENT DOCUMENTS 2006, OO18909 A1 1/2006 Oliner et al. 2006, O104968 A1 5, 2006 Bookbinder et al. 5,580,717 A 12/1996 Dower et al. 2006.0160164 A1 7/2006 Miller et al. 2007/OOO3567 A1 1/2007 Paterson et al. 3. A leg R3s, al. 2007, 0071675 A1 3, 2007 Wu et al. 5,624,821 A 4/1997 Winter et al. 2007/O160576 A1 7/2007 Arnott et al. 5,627,052 A 5, 1997 Schrader et al. 2007/0196371 A1 8, 2007 Kuestner et al. 5,641,870 A 6/1997 Rinderknecht et al. 2008.0020401 A1 1/2008 Grenier et al. 5,648,260 A 7, 1997 Winter et al. 2008/0219971 A1 9, 2008 Smith et al. 2008/0248493 A1 10/2008 Mattingly et al. 3597; A 88: Railal. 2008/0269.467 A1 10, 2008 Alan et al. 5,679,377 A 10, 1997 Bernstein et al. 2010.0099.103 A1 4, 2010 Hsieh et al. 5,693,762 A 12/1997 Queen et al. 2010.0167301 A1 7/2010 Collier et al. 5,698,426 A 12/1997 Huse et al. 2012.0034160 A1 2, 2012 Ghayur et al. 5,714,350 A 2f1998 CO et al. 2014/0335564 A1 11/2014 Hsieh 5,714,352 A 2f1998 Jakobovits et al. 2014/0343267 A1 11/2014 Hsieh 5,723,323 A 3, 1998 Kauffman et al. 2014/0348834 A1 11/2014 Hsieh 5,733,743 A 3, 1998 Johnson et al. 2014,034.8856 A1 11/2014 Hsieh 5,736,137 A 4, 1998 Anderson et al. 2014/0356909 A1 12/2014 Hsieh 5,750,753 A 5, 1998 Kimae et al. 5,763,192 A 6/1998 Kauffman et al. FOREIGN PATENT DOCUMENTS 5,766,886 A 6, 1998 Studnicka et al. 5,780,225 A 7/1998 Wigler et al. 5,783,699 A 7/1998 Mattingly et al. E. 83.88 E. 5,814,476 A 9, 1998 Kauffman et al. EP O519596 B1 2, 2005 5,824,514 A 10, 1998 Kauffman et al. WO WO9005144 A1 5, 1990 5,891,996 A 4, 1999 Mateo de Acosta del Rio et al. WO WO9014443 11, 1990 5,912,015 A 6, 1999 Bernstein et al. WO WO9105548 5, 1991 5,934.272 A 8/1999 Lloyd et al. WO WO9110741 7, 1991 5,976,862 A 11/1999 Kauffman et al. WO WO92O2551 2, 1992 5,985,615. A 1 1/1999 Jakobovits et al. WO WO9211272 7, 1992 5,989.463 A 1 1/1999 Tracy et al. WO WO9215679 9, 1992 6,066,719 A 5/2000 Zapata WO WO922O791 11, 1992 6,114,598 A 9/2000 Kucherlapati et al. WO WO9306213 A1 4f1993 6,130,364. A 10/2000 Jakobovits et al. WO WO9311236 6, 1993 6,204,023 B1 3, 2001 Robinson et al. WO WO9418219 8, 1994 6.214.984 B1 4/2001 Zapata WO WO9515982 6, 1995 6,258,562 B1 7/2001 Salfeld et al. WO WO962O698 T 1996 6,506,883 B2 1/2003 Meteo de Acosta del Rio et al. WO WO964O210 12/1996 6,660,843 B1 12/2003 Feige et al. WO WO972OO32 6, 1997 6,914,128 B1 7/2005 Salfeld et al. WO WO9732572 9, 1997 7,247,301 B2 7/2007 van de Winkel et al. WO WO9744O13 11, 1997 7,838,638 B2 11/2010 Allan et al. WO WO9824893 6, 1998 2002/0137134 A1 9/2002 Gerngross WO WO985O433 11, 1998 2003/009 1561 A1 5/2003 van de Winkel et al. WO WO991.5154 4f1999 2003/0170881 A1 9, 2003 Davis et al. WO WO992O253 4f1999 2003. O1863.74 A1 10, 2003 Hufton et al. WO WO992SO44 5, 1999 2003/0219438 A1 11, 2003 Salfeld et al. WO WO994.5031 9, 1999 2004/OO18577 A1 1/2004 Campbell et al. WO WO995.1773 10, 1999 2004, OO18590 A1 1/2004 Gerngross WO WO9953049 10, 1999 2005, OO42664 A1 2, 2005 Wu et al. WO WO99.54342 10, 1999 US 9,663,587 B2 Page 3 (56) References Cited Kipriyanov et al., “Single-chain antibody streptavidin fusions: Tetrameric bifunctional scFv-complexes with biotin binding activ FOREIGN PATENT DOCUMENTS ity and enhanced affinity to antigen.” Hum. Antibod. Hybridomas, 6:93-101 (1995). WO WO9966903 12/1999 WO WOOOO9560 2, 2000 Kirkham et al., “Synovial membrane cytokine expression is pre WO WOOO34337 6, 2000 dictive of joint damage progression in rheumatoid arthritis.” Arthri WO WOOO37.504 6, 2000 tis Rheum.